We evaluated the usefulness, inroutine newborn screening for congenital hypothyroidism, of a time-resolved fluoroimmunoassay kit (DEL.FIA Neonatal TSH) for the determination of thyrotropin (TSH) in dried blood spots. A total of 11 531 dried blood samples from newborns were tested in parallel in each of two Swiss screening laboratories, by RIA and DELFIA. Six cases of confirmed congenital hypothyroidism were detected during the study period. Since 1977, every newborn baby in Switzerland has been 'screened for congenital hypothyroidism by thyrotropin radioimmunoassay (TSH-RIA) of dried blood spotted on filter paper (1).
Materials and Methods

Reagents
All reagents used in this study are contained in the "DELFIA Neonatal TSH" kits, as supplied by LKB-Wallac, Turku, Finland.
The kit consists of: #{149} microtiter plates, divided into eight strips of 12 wells each, coated with monoclonal anti-/3-TSH antibody; #{149} monoclonal anti-TSH antibody labeled with europium; #{149} Tris HC1 buffer (50 mmolJL, pH 7.75), containing 5 g of bovine serum albumin, 0.5 g of bovine gamma globulin, 9 g of NaC1, and 0. dried at room temperature, and stored in a plastic box at 4#{176}C until used. We used the same series of standards all during this three-month study. The TSH content of the standard solutions was measured by RIA of an aliquot of the plasma.
Equipment
We measured the endpoint fluorescence in an icus fluonimeter (LKB-Wallac), equipped with a printer and a dual floppy-disc drive. We calculated standard curves and the concentrations of unknown samples by using the datareduction package supplied with the fluorimeter, with a spline transformation for the fitting of the standard curve. We used a microtiter plate shaker (Dynatech) for shaking. the wells. In Lab. 1 the discs were always punched from the edge of a blood spot; in Lab. 2 they were punched from the middle of the blood spot.
Samples
Comparison of Blood-Spot TSH by AlA and DELFIA
All the 11 731 samples tested in the DELFIA had previously been measured in the RIA system used in Switzerland for neonatal thyroid screening (1).
Statistics
Within-and between-assay precision was calculated according to Rodbard (8).
Test Procedure
The kit was used according to the manufacturer's instructions. For all pipetting we used Socorex 861 multidispensing pipettes (Socorex, Renens, Switzerland). A typical run consisted of one to four plates, i.e., 72-360 unknown samples. Standards and quality-control samples were always run in duplicate, but unknown samples had to be assayed singly, owing to the scarcity of material. The 3-mm discs were punched directly into the prewashed wells, followed by 200 oL of Eu-labeled antibody solution. The plates were shaken Interassay precision of the method was assessedin each laboratory by use of three quality-control samples, included in singlet in every run (Table 1) . Intra-assay precision ( 
Discussion
The aim of our study was to investigate the suitability of the DELFIA NH assay for large-scale neonatal thyroid screening.
The frequency distribution of the 11 531 DELFIA TSH results in the two laboratories (Figure 2) shows that 99.7% of all tested samples gave results below 25 milli-int. units per liter of blood, a value which we use as cutoff point in TSH-RIA. These results compare favorably with those for our RIA (Table 3 ). There is a clear tendency towards lower values (i.e., better sensitivity) in the DELFIA. This is ascribable to the greater specificity of the monoclonal anti--TSH antibody used in the DELFIA as compared with the polyclonal anti-TSH used in the RIA. This greater antibody specificity, together with the "sandwich" or "reagent excess" assay principle, results in an overall greater sensitivity of the DELFIA (9, 10).
Laboratory 2 obtained slightly lower concentration values than Lab. 1 (Figure 2) . In Lab. 1 the discs were always punched from the edge of the blood spot; in Lab. 2 the disc was always punched from the middle. As described by H#{246}pfner (11), a slight chromatographic effect causes uneven distribution of TSH in the blood spot. Hopfner therefore advocates the use of discs 8mm in diameter, in order to get a sample with evenly distributed TSH. Owing to the size of the wells, however, we are restricted to the use of discs3 to 5 mm in diameter.
During the study period a total of 37 samples (0.3%) required further attentionbecause of resultsexceeding 25 milli-int. unitsfL (23 in Lab. 1, 14 in Lab. 2). Of these 37 samples, 6 (16%) were confirmed as primary hypothyroidism (onein Lab. 1, five in Lab. 2). Another 12 samples (10 in Lab. 1, two in Lab. 2) were taken during the first postnatal day and could be considered as physiologically increased (33%). The remaining 19 samples (12 for Lab. 1, seven for Lab. 2) proved normal (TSH <25 milli-int. unitsfL) at retesting. These samples can be considered as false positives after single testing this corresponds to the low rate of 0.16%. All of the "false-positive" samples had results between 25 and 30 milli-int. unitsfL, which, based on more than eight years of screening experience with H-R1A, are values very unlikely to be found in hypothyroid babies. The inter-and intra-assay precision of the DELFIA are adequate for a screening assay, and the sensitivity (1 milliint. unit/L) compares favorably with that of our RIA (5 miiiint. unitsfL). The correlation between RIA and DELFIA in both laboratories was highly significant (p <0.001).
Although, as shown in Table 2 , even a 4-h incubation gives good results, we prefer to use an overnight incubation, mainly for convenience: if we start the incubation around 15:00 h, all the day's samples can be included and results are ready by 11:00 h the next morning. If the sample has been taken on the fifth postnatal day, this schedule allows initiation of therapy by day 7 or 8, as compared with day 9 or 10 in our actual program.
The DELFIA assay can be run manually, but it is easily automated. Our trials with automated pipetting equipment (Sampler 505; TECAN AG, Hombrechtikon, Switzerland), gave good results. This means that the punching of the discs from the ifiter paper cards need be the only manual step in this assay, every other operation-dispensing of reagents, washing of wells, measurement of fluorescence, and calculation of results-being therefore automatic.
We conclude that the DELFIA Neonatal TSH assay is well suited for screening for congenital hypothyroidism on a largescale, and represents a true and viable alternative to radioimmunoassay.
